Literature DB >> 8281673

Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.

J M Canty1, J S Schwartz.   

Abstract

BACKGROUND: Although epicardial coronary arteries dilate in response to changes in flow, the mechanisms responsible for this and the mechanical stimuli that are sensed by the endothelium are not completely defined. We performed the present study to determine the importance of nitric oxide in eliciting epicardial dilation to sustained changes in mean flow and pulse frequency in the coronary circulation of conscious dogs. METHODS AND
RESULTS: Dogs were chronically instrumented with a circumflex coronary occluder, piezoelectric crystals to measure epicardial diameter, and a coronary artery catheter placed distal to the crystals for intracoronary drug infusion. Studies were conducted in dogs in the conscious state. We inhibited nitric oxide production by administering the arginine analog N omega-nitro-L-arginine methyl ester (L-NAME, 10 mg/kg IV), which attenuated the epicardial artery diameter changes to left atrial infusions of acetylcholine (10 micrograms/min) from 140 +/- 23 (+/- SEM) to 46 +/- 20 microns (P < .05). Epicardial dilation to sustained increases in mean coronary artery at a constant heart rate. Intracoronary adenosine increased mean flow to the same extent (180 +/- 21 versus 177 +/- 24 mL/min after L-NAME, P = NS), but inhibiting nitric oxide production had no effect on flow-mediated epicardial dilation, with coronary diameter increasing by 264 +/- 36 microns under control conditions and 294 +/- 67 microns after L-NAME (P = NS). In contrast, when pulse frequency was increased by pacing to a rate of 200 beats per minute, mean coronary flow increased to a similar level (78 +/- 9 versus 75 +/- 9 mL/min after L-NAME), but the epicardial diameter change to pacing was attenuated from 170 +/- 29 microns under control conditions to 54 +/- 23 microns after L-NAME (P < .01).
CONCLUSIONS: These results demonstrate that in vivo, nitric oxide production is primarily responsible for eliciting epicardial coronary vasodilation to endothelium-dependent agonists and changes in coronary flow pulse frequency. The failure of L-NAME to affect epicardial vasodilation during sustained increases in mean flow when pulse frequency is held constant suggests that additional mechanisms are involved in flow-mediated vasodilation of epicardial coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8281673     DOI: 10.1161/01.cir.89.1.375

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Regulation of the coronary vasomotor tone: What we know and where we need to go.

Authors:  E Toyota; R Koshida; N Hattan; W M Chilian
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

2.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

3.  Mechanical compression elicits NO-dependent increases in coronary flow.

Authors:  Dong Sun; An Huang; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-12       Impact factor: 4.733

4.  Plasma detection of NO by a catheter.

Authors:  Masami Goto; Seiichi Mochizuki
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

Review 5.  Vascular effects of exercise: endothelial adaptations beyond active muscle beds.

Authors:  Jaume Padilla; Grant H Simmons; Shawn B Bender; Arturo A Arce-Esquivel; Jeffrey J Whyte; M Harold Laughlin
Journal:  Physiology (Bethesda)       Date:  2011-06

Review 6.  Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.

Authors:  D J Green; G O'Driscoll; B A Blanksby; R R Taylor
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

Review 7.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

8.  Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.

Authors:  Q Liu; I Nakae; M Takahashi; A Takaoka; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

9.  MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery.

Authors:  Maggie M Kuo; Dae Hee Kim; Sandeep Jandu; Yehudit Bergman; Siqi Tan; Huilei Wang; Deepesh R Pandey; Theodore P Abraham; Artin A Shoukas; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

Review 10.  Regulation of the human coronary microcirculation.

Authors:  Andreas M Beyer; David D Gutterman
Journal:  J Mol Cell Cardiol       Date:  2011-10-12       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.